Janux Therapeutics's chart data is dated 2026-10-09. Recorded technical signals: Bollinger breakout, MACD bullish cross. There are 4 published signal records.
Janux Therapeutics last closed at $18.39 (-0.59%) on 2026-10-09. Signals today: Bollinger breakout, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -11.3×. Its overall grade ranks 90 of 736 stocks in Healthcare.
About this company
Janux Therapeutics last closed at $18.39 (-0.59%) on 2026-10-09. Signals today: Bollinger breakout, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 90/736
Valuation grade C+
Related stocks
- Bristol Myers SquibbCustomer
JANX의 주요 파트너이자 공동개발/라이선스 협력사로, 기술 상업화 측면에서 핵심 고객·협력사
- MerckCustomer
JANX의 플랫폼 기술 활용 가능성이 있는 대형 제약사로, 종양 파이프라인 협력 대상
- PfizerCompetitor
면역항암·이중특이성 항체 개발에서 경쟁하는 대형 제약사
About Janux Therapeutics
- What technical signals does Janux Therapeutics (JANX) have?
- Janux Therapeutics current technical signals: Bollinger breakout, MACD bullish cross.
- Is Janux Therapeutics a cup-and-handle pattern?
- No. Janux Therapeutics has no valid Cup signal right now.
- What published figures are available for Janux Therapeutics?
- Market cap: $1.11B. Trailing 12 months PER: -11.3×. Latest quarter PBR: 1.25×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Janux Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.